HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Determination of the discriminating concentration of chlorfenapyr (pyrrole) and Anopheles gambiae sensu lato susceptibility testing in preparation for distribution of Interceptor® G2 insecticide-treated nets.

AbstractBACKGROUND:
Following agricultural use and large-scale distribution of insecticide-treated nets (ITNs), malaria vector resistance to pyrethroids is widespread in sub-Saharan Africa. Interceptor® G2 is a new dual active ingredient (AI) ITN treated with alpha-cypermethrin and chlorfenapyr for the control of pyrethroid-resistant malaria vectors. In anticipation of these new nets being more widely distributed, testing was conducted to develop a chlorfenapyr susceptibility bioassay protocol and gather susceptibility information.
METHODS:
Bottle bioassay tests were conducted using five concentrations of chlorfenapyr at 12.5, 25, 50, 100, and 200 µg AI/bottle in 10 countries in sub-Saharan Africa using 13,639 wild-collected Anopheles gambiae sensu lato (s.l.) (56 vector populations per dose) and 4,494 pyrethroid-susceptible insectary mosquitoes from 8 colonized strains. In parallel, susceptibility tests were conducted using a provisional discriminating concentration of 100 µg AI/bottle in 16 countries using 23,422 wild-collected, pyrethroid-resistant An. gambiae s.l. (259 vector populations). Exposure time was 60 min, with mortality recorded at 24, 48 and 72 h after exposure.
RESULTS:
Median mortality rates (up to 72 h after exposure) of insectary colony mosquitoes was 100% at all five concentrations tested, but the lowest dose to kill all mosquitoes tested was 50 µg AI/bottle. The median 72-h mortality of wild An. gambiae s.l. in 10 countries was 71.5, 90.5, 96.5, 100, and 100% at concentrations of 12.5, 25, 50, 100, and 200 µg AI/bottle, respectively. Log-probit analysis of the five concentrations tested determined that the LC95 of wild An. gambiae s.l. was 67.9 µg AI/bottle (95% CI: 48.8-119.5). The discriminating concentration of 203.8 µg AI/bottle (95% CI: 146-359) was calculated by multiplying the LC95 by three. However, the difference in mortality between 100 and 200 µg AI/bottle was minimal and large-scale testing using 100 µg AI/bottle with wild An. gambiae s.l. in 16 countries showed that this concentration was generally suitable, with a median mortality rate of 100% at 72 h.
CONCLUSIONS:
This study determined that 100 or 200 µg AI/bottle chlorfenapyr in bottle bioassays are suitable discriminating concentrations for monitoring susceptibility of wild An. gambiae s.l., using mortality recorded up to 72 h. Testing in 16 countries in sub-Saharan Africa demonstrated vector susceptibility to chlorfenapyr, including mosquitoes with multiple resistance mechanisms to pyrethroids.
AuthorsRichard M Oxborough, Aklilu Seyoum, Yemane Yihdego, Joseph Chabi, Francis Wat'senga, Fiacre R Agossa, Sylvester Coleman, Samdi Lazarus Musa, Ousmane Faye, Michael Okia, Mohamed Bayoh, Evelyne Alyko, Jean-Desire Rakotoson, Hieronymo Masendu, Arthur Sovi, Libasse Gadiaga, Bernard Abong'o, Kevin Opondo, Ibrahima Baber, Roch Dabire, Virgile Gnanguenon, Gedeon Yohannes, Kenyssony Varela, Etienne Fondjo, Jenny Carlson, Jennifer S Armistead, Dereje Dengela
JournalMalaria journal (Malar J) Vol. 20 Issue 1 Pg. 316 (Jul 14 2021) ISSN: 1475-2875 [Electronic] England
PMID34261475 (Publication Type: Journal Article)
Copyright© 2021. The Author(s).
Chemical References
  • Insecticides
  • Pyrethrins
  • chlorfenapyr
Topics
  • Animals
  • Anopheles (drug effects)
  • Dose-Response Relationship, Drug
  • Insecticide Resistance
  • Insecticide-Treated Bednets
  • Insecticides (pharmacology)
  • Pyrethrins (pharmacology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: